Quartet Medicine Garners $6,250,000 Series A Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=aa74ef2e-2514-42c8-98f3-4714e112e236
Date
10/7/2015
Company Name
Quartet Medicine
Mailing Address
400 Technology Square 10th Floor Cambridge, MA 02139 USA
Company Description
Quartet Medicine is a private, biotechnology company focused on discovering and developing novel treatments for chronic pain and inflammation. Human genetics and preclinical target validation data point to increased tetrahydrobiopterin (BH4) as a critical mediator of peripheral nerve dysfunction and immune cell regulation.
Website
http://www.quartetmedicine.com
Transaction Type
Venture Equity
Transaction Amount
$6,250,000
Transaction Round
Series A
Proceeds Purposes
Quartet plans to use the funding to advance its lead program focused on modulating tetrahydrobiopterin (BH4) through early clinical testing over the next two years.
M&A Terms
Venture Investor
Remeditex Ventures
Venture Investor
Undisclosed